Open research questions in Prenatal Screening and Diagnostics
201 unresolved questions extracted from the limitations and future-work sections of 962 Prenatal Screening and Diagnostics papers in our library. Each links back to the study that raised it.
What the literature leaves open
Longitudinal studies to assess the outcomes of pregnancies with structural anomalies, - Studies to evaluate the effectiveness of different screening protocols, - Research to improve the accuracy of diagnosis and non-directive counselling
Structural Fetal Anomalies Identified During First-Trimester Screening: A Single-Centre Experience in Romania · 2026 · DOIThe study faced challenges in terms of the limited number of poor-quality blastocysts in the PGT-FET cycle, which were excluded from the statistical analysis. The study had to account for various factors, including embryo quality and maternal age, when comparing the outcomes of day 5 and day 6 blastocyst biopsies. The study did not explicitly state the challenges it faced, but it had to address the controversy surrounding the optimal timing for blastocyst biopsy during PGT.
Evaluation of day 5 versus day 6 blastocyst biopsy in preimplantation genetic testing: clinical and neonatal outcomes · 2025 · DOIthe study was retrospective, - the sample size for poorly developed blastocysts was limited, - the study only included patients with common indications for PGT
Evaluation of day 5 versus day 6 blastocyst biopsy in preimplantation genetic testing: clinical and neonatal outcomes · 2025 · DOIHowever, the impact of early versus late TOP due to fetal anomalies remains unclear.
Early versus late termination for fetal anomalies: Women's perspectives and psychological impact in a mixed methods study · 2026 · DOICase series and reports regarding pregnancies in individuals with specific RD exist, but there is no data on the outcome of pregnancies in the overall group.
However, limited information is available regarding the impact of thalassemia carrier status on embryo euploidy, developmental competence, and embryo availability.
Thalassemia does not significantly affect embryo ploidy outcomes in women undergoing IVF with preimplantation genetic testing · 2026 · DOI4 mm remain controversial, particularly regarding whether to first calculate the combined first trimester screening test or to proceed directly with invasive testing.
Outcomes associated with fetal nuchal translucency between 3.0 and 3.4 mm in the first trimester · 2025 · DOIAt present, whole exome sequencing (WES) has been applied in SD fetuses, but there is still a lack of data accumulation.
Little is known about how much people from Black communities have contributed to this research.
Are People From Black Communities Proportionately Represented in UK and US Studies Examining Views on Screening and Diagnostic Genetic Testing in Pregnancy? A Scoping Review · 2025 · DOIThe relationship between these biomarkers and embryo chromosomal status remains complex and poorly understood.
Very little is known about RT control in early mouse embryos, and how it correlates with the start of transcription during zygote gene activation (ZGA), at the 2-cell stage.
Single cell multiomics approach to analyze replication timing and gene expression in mouse preimplantation embryos · 2025 · DOIHowever, despite the limited sample size, our findings may not be applicable to those aged 35 or over; therefore, larger cohort studies are imperative for the validation of our results.
Impact of blastocyst biopsy for preimplantation genetic testing on maternal and neonatal outcomes following single frozen embryo transfer cycles · 2025 · DOICardiac and vascular anomalies are common in ART derived neonates but have not been described in calves.
Cardiovascular phenotype analysis in large and abnormal offspring calves in relation to assisted reproductive technology · 2025 · DOIA patent ductus arteriosus (PDA) was seen in 6/7 calves and could not be evaluated in one calf but auscultation was consistent with a PDA.
Cardiovascular phenotype analysis in large and abnormal offspring calves in relation to assisted reproductive technology · 2025 · DOIBackground Male sperm DNA fragmentation (SDF) may be associated with assisted reproductive technology (ART) outcomes, but the impact of SDF on the occurrence of aneuploid-related miscarriage remains controversial.
Elevated sperm DNA fragmentation is correlated with an increased chromosomal aneuploidy rate of miscarried conceptus in women of advanced age undergoing fresh embryo transfer cycle · 2024 · DOIBackground Optimal protocols for frozen-thawed embryo transfer (FET) after preimplantation genetic testing (PGT) remain unclear.
Comparing Day 5 versus Day 6 euploid blastocyst in frozen embryo transfer and developing a predictive model for optimizing outcomes: a retrospective cohort study · 2024 · DOIThere are multiple fates for MN, including sequestration into CFs, but the molecular mechanism(s) by which this occurs remains unclear.
Insights into embryonic chromosomal instability: mechanisms of DNA elimination during mammalian preimplantation development · 2024 · DOIOur results suggest that re-analysis of sequencing data from routine WGS assays has the potential to obtain large-scale CNV population frequencies, which are not well known and may provide valuable information to support the classification and interpretation of this type of genetic variation.
Understanding genetic variability: exploring large-scale copy number variants through non-invasive prenatal testing in European populations · 2024 · DOIThese observations suggest a selective loss of aneuploid cells from human embryos, but the underlying mechanisms are not yet fully understood.
Complex aneuploidy triggers autophagy and p53-mediated apoptosis and impairs the second lineage segregation in human preimplantation embryos · 2024 · DOIHowever, the molecular mechanism underlying this morphologic anomaly and head-to-tail coupling apparatus remains elusive.
Loss of CCDC188 causes male infertility with defects in the sperm head–neck connection in mice · 2024 · DOIThe minimum fetal fraction (FF) threshold at which dPCR retains diagnostic accuracy remains unknown. Further studies should address this by evaluating performance at lower FF to better define the assay's limitations and potential in early gestation or in individuals with high maternal BMI.
The current framework for determining the legal and ethical status of a fetus is limited and does not fully reflect contemporary clinical realities. The paper identifies a need for a flexible ethical framework that can accommodate both medical realities and patient-centered values.
Is a Fetus a Living Entity? Reframing the Question of Its Right to Survive in Contemporary Maternal–Fetal Medicine · 2026 · DOIMonogenic recessive diseases have not previously benefited from NIPD due to the inability to separate maternal and fetal DNA. There is a need for a minimally invasive approach for NIPD of SCD.
Implementation of third-generation digital PCR for non-invasive prenatal diagnosis of sickle cell disease and early detection. Pilot study · 2026 · DOIInvestigation of the relationship between NIPT results and maternal malignancy, - Development of standardized protocols for reporting NIPT results, - Improvement of fetal fraction calculation methods
Recurrent Hodgkin’s Lymphoma Detected Using Abnormal NIPT in Pregnancy: A Case Report and Literature Review · 2026 · DOIThe paper identifies a gap in the lack of standardized protocols for reporting abnormal NIPT results. It highlights the need for further investigation into the association between abnormal NIPT results and maternal malignancy.
Recurrent Hodgkin’s Lymphoma Detected Using Abnormal NIPT in Pregnancy: A Case Report and Literature Review · 2026 · DOI
Most-cited papers in Prenatal Screening and Diagnostics
- Presence of fetal DNA in maternal plasma and serum · The Lancet · 1997 · 2,595 citations
- The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening · Fertility and Sterility · 2013 · 942 citations
- Health Supervision for Children With Down Syndrome · PEDIATRICS · 2011 · 887 citations
- The Denver Developmental Screening Test · The Journal of Pediatrics · 1967 · 768 citations
- A Population-Based Study of the 22q11.2 Deletion: Phenotype, Incidence, and Contribution to Major Birth Defects in the Population · PEDIATRICS · 2003 · 570 citations
- Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial · Fertility and Sterility · 2019 · 527 citations
- Prenatal Genetic Testing and Screening: Constructing Needs and Reinforcing Inequities · American Journal of Law & Medicine · 1991 · 497 citations
- Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein level · BJOG An International Journal of Obstetrics & Gynaecology · 1987 · 488 citations
- Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts · Human Reproduction · 2014 · 480 citations
- The National Birth Defects Prevention Study · Public Health Reports · 2001 · 463 citations
Most recent work
- Impact of different types of embryonic mosaicism on pregnancy outcomes · Fertility and Sterility · 2026
- Early versus late termination for fetal anomalies: Women's perspectives and psychological impact in a mixed methods study · Acta Obstetricia Et Gynecologica Scandinavica · 2026
- Prenatal Diagnosis and Novel Therapeutics in Treatment of Genetic Conditions: Challenges and Opportunities · Clinical Therapeutics · 2026
- Evaluation of short video quality and reliability of non-invasive prenatal testing on TikTok and Bilibili platforms: a cross-sectional study · BMC Pregnancy and Childbirth · 2026
- Modelling the cost-effectiveness of non-invasive prenatal testing in the English sickle cell and thalassaemia screening pathway · Diagnostic and Prognostic Research · 2026
- What is at stake in genetic newborn screening for rare diseases? – An exploratory qualitative study of parents’ and expectant parents’ concerns in the Screen4Care project · Public Health Genomics · 2026
- Cell-free DNA fragmentome analysis informs pregnancy outcome in patients with immune-mediated disease · Science Translational Medicine · 2026
- The landscape of chromosomal aberrations in couples seeking assisted reproductive treatment · Human Reproduction · 2026
- Navigating uncertainty in PGT-A: aligning analytical, biological, and clinical evidence · Human Reproduction · 2026
- Pregnancies in women with rare diseases: Selected maternal and perinatal outcomes · Acta Obstetricia Et Gynecologica Scandinavica · 2026
Find a gap in your own Prenatal Screening and Diagnostics sub-topic
This page shows what the Prenatal Screening and Diagnostics literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →